Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Optavia | | | | | | | 202.2 | 206.7 |
| Other | | | | | | | 70.6 | 78.6 |
| Total revenues | 1,526.1 | 934.8 | 713.7 | 501.0 | 301.6 | 274.5 | 272.8 | 285.3 |
| Revenue growth [+] | 63.2% | 31.0% | 42.4% | 66.1% | 9.8% | 0.6% | -4.4% | -12.0% |
| Optavia | | | | | | | -2.1% | -9.6% |
| Medifast Direct | | | | | | | -14.9% | -24.3% |
| Cost of goods sold | 398.5 | 237.0 | 176.8 | 121.1 | 73.8 | 68.9 | 71.5 | 76.1 |
| Gross profit | 1,127.6 | 697.8 | 536.9 | 379.9 | 227.8 | 205.7 | 201.3 | 209.2 |
| Gross margin | 73.9% | 74.6% | 75.2% | 75.8% | 75.5% | 74.9% | 73.8% | 73.3% |
| Selling, general and administrative | 911.4 | 563.7 | 445.8 | 310.8 | 188.2 | 179.5 | 173.6 | 180.2 |
| Other operating expenses | | | | | | -0.7 | -1.0 | -1.2 |
| EBITDA [+] | 223.1 | 138.5 | 95.7 | 73.5 | 43.8 | 32.3 | 35.8 | 38.3 |
| EBITDA growth | 61.1% | 44.8% | 30.2% | 67.6% | 35.9% | -9.9% | -6.5% | -17.3% |
| EBITDA margin | 14.6% | 14.8% | 13.4% | 14.7% | 14.5% | 11.8% | 13.1% | 13.4% |
| Depreciation and amortization | 6.8 | 4.3 | 4.6 | 4.4 | 4.2 | 5.4 | 7.1 | 8.1 |
| EBIT [+] | 216.2 | 134.2 | 91.0 | 69.1 | 39.6 | 26.9 | 28.7 | 30.2 |
| EBIT growth | 61.2% | 47.4% | 31.8% | 74.3% | 47.6% | -6.4% | -5.2% | -21.3% |
| EBIT margin | 14.2% | 14.4% | 12.8% | 13.8% | 13.1% | 9.8% | 10.5% | 10.6% |
| Interest income, net [+] | -0.2 | 0.2 | 1.3 | 1.3 | 0.6 | 0.3 | 0.7 | 0.7 |
| Interest expense | 0.2 | | | | | | | |
| Interest income | | 0.2 | 1.3 | 1.3 | 0.6 | 0.3 | 0.7 | 0.7 |
| Other income (expense), net | 0.1 | -0.1 | 0.0 | 0.2 | 0.1 | 0.0 | 0.3 | 0.7 |
| Pre-tax income | 216.1 | 134.3 | 92.4 | 70.5 | 40.3 | 27.1 | 29.7 | 31.7 |
| Income taxes | 52.1 | 31.4 | 14.4 | 14.8 | 12.6 | 9.3 | 10.1 | 10.7 |
| Tax rate | 24.1% | 23.4% | 15.6% | 20.9% | 31.3% | 34.2% | 34.1% | 33.6% |
| Net income | 164.0 | 102.9 | 77.9 | 55.8 | 27.7 | 17.8 | 20.1 | 13.2 |
| Net margin | 10.7% | 11.0% | 10.9% | 11.1% | 9.2% | 6.5% | 7.4% | 4.6% |
| |
| Basic EPS [+] | $14.01 | $8.74 | $6.62 | $4.67 | $2.32 | $1.51 | $1.64 | $1.66 |
| Growth | 60.4% | 32.0% | 41.8% | 100.9% | 54.4% | -8.0% | -1.4% | -15.7% |
| Diluted EPS [+] | $13.89 | $8.68 | $6.43 | $4.62 | $2.29 | $1.49 | $1.62 | $1.65 |
| Growth | 60.0% | 35.0% | 39.2% | 101.4% | 53.6% | -7.9% | -1.5% | -16.2% |
| |
| Dividends per share [+] | $5.68 | $4.52 | $3.38 | $2.19 | $1.44 | $1.07 | $0.25 | |
| Growth | 25.7% | 33.7% | 54.3% | 52.1% | 34.6% | 328.0% | | |
| |
| Shares outstanding (basic) [+] | 11.7 | 11.8 | 11.8 | 11.9 | 11.9 | 11.8 | 12.0 | 12.7 |
| Growth | -0.6% | 0.0% | -1.5% | 0.2% | 0.7% | -1.0% | -5.6% | -8.0% |
| Shares outstanding (diluted) [+] | 11.8 | 11.9 | 12.1 | 12.1 | 12.1 | 11.9 | 12.1 | 12.8 |
| Growth | -0.3% | -2.2% | 0.3% | -0.1% | 1.2% | -1.0% | -5.5% | -7.5% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|